Whether we’re talking offices, medical congresses, or advisory board meetings, the term “hybrid” is often used to signal the ideal state. The place where everyone’s needs are being met.
As the world passes the year and a half mark of the COVID-19 pandemic, the evolving ‘new normal’ experience across the healthcare sector has brought huge changes to the way pharma engages h
The healthcare professional (HCP) meeting landscape is evolving, but even as it adjusts to the demands of the digital age new research has shown that face-to-face meetings retain a prominent place
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.